YORDON JEFFREY
Insider CIK 1189013 · ATNX See Remarks · SGNT Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNX Athenex, Inc. | M Exercise deriv | 2022-08-03 | 2022-08-15 | 12,500 | — | $0 | 37,500 | SEC↗ |
| ATNX Athenex, Inc. | F Tax w/h | 2022-08-03 | 2022-08-15 | 3,663 | $0.58 | $2.1K | 245,943 | SEC↗ |
| ATNX Athenex, Inc. | M Exercise | 2022-08-03 | 2022-08-15 | 12,500 | — | $0 | 249,606 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2021-08-03 | 2021-08-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATNX Athenex, Inc. | M Exercise deriv | 2020-09-10 | 2020-09-10 | 18,180 | — | $0 | 211,820 | SEC↗ |
| ATNX Athenex, Inc. | M Exercise | 2020-09-10 | 2020-09-10 | 18,180 | $11.00 | $200.0K | 237,106 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2020-06-05 | 2020-08-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATNX Athenex, Inc. | P Buy | 2020-03-12 | 2020-03-12 | 10,000 | $8.14 | $81.4K | 218,926 | SEC↗ |
| ATNX Athenex, Inc. | A Award | 2019-04-16 | 2019-04-17 | 10,717 | — | $0 | 208,926 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATNX Athenex, Inc. | P Buy | 2018-11-14 | 2018-11-14 | 9,500 | $10.49 | $99.7K | 198,209 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2018-03-27 | 2019-03-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ATNX Athenex, Inc. | P Buy | 2018-03-26 | 2018-03-26 | 5,000 | $14.69 | $73.5K | 188,709 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2017-06-19 | 2017-06-21 | 230,000 | — | $0 | 230,000 | SEC↗ |
| ATNX Athenex, Inc. | A Award deriv | 2017-06-13 | 2018-08-21 | 230,000 | — | $0 | 230,000 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | G Gift | 2015-02-27 | 2015-04-01 | 48,850 | — | $0 | 616,076 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-02-25 | 2015-02-27 | 18,468 | — | $0 | 18,468 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2015-02-25 | 2015-02-27 | 9,945 | — | $0 | 686,014 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-22 | 2015-02-24 | 918 | $28.50 | $26.2K | 676,069 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-21 | 2015-02-24 | 1,227 | $28.50 | $35.0K | 676,987 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2015-02-18 | 2015-02-20 | 1,053 | $27.22 | $28.7K | 678,214 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2014-02-22 | 2014-02-24 | 955 | $21.75 | $20.8K | 679,267 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2014-02-21 | 2014-02-24 | 1,279 | $21.84 | $27.9K | 680,222 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2014-02-18 | 2014-02-19 | 23,936 | — | $0 | 23,936 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2014-02-18 | 2014-02-19 | 13,393 | — | $0 | 681,501 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | S Sale | 2013-09-16 | 2013-09-17 | 85,813 | $20.03 | $1.72M | 669,036 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | F Tax w/h | 2013-02-22 | 2014-01-02 | 928 | $16.85 | $15.6K | 668,108 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2013-02-21 | 2013-02-25 | 27,282 | — | $0 | 27,282 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2013-02-21 | 2013-02-25 | 15,805 | — | $0 | 754,849 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-02-22 | 2012-02-24 | 21,090 | — | $0 | 21,090 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award | 2012-02-22 | 2012-02-24 | 11,800 | — | $0 | 703,958 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2011-07-23 | 2012-04-19 | 15,948 | — | $0 | 47,845 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2011-07-23 | 2012-04-19 | 15,948 | $4.31 | $68.7K | 739,044 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2011-06-01 | 2012-04-19 | 19,138 | — | $0 | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2011-06-01 | 2012-04-19 | 19,138 | $4.23 | $81.0K | 723,096 | SEC↗ |